PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sorbonne University, GRC 5 Predictive onco-uro, APHP, Urology, Pitié-Salpétrière Hospital, 75013 Paris, France.\', \'Department of Cancer Medicine, Gustave Roussy Institute, University Paris-Saclay, Villejuif, France.\', \'Sorbonne University, GRC 5 Predictive onco-uro, APHP, Urology, Pitié-Salpétrière Hospital, 75013 Paris, France. Electronic address: morgan.roupret@aphp.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0302-2838(20)30302-X10.1016/j.eururo.2020.04.039
?:doi
?:hasPublicationType
?:journal
  • European urology
is ?:pmid of
?:pmid
?:pmid
  • 32349928
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 8.593
?:rankingScore_hIndex
  • 173
is ?:relation_isRelatedTo_publication of
?:title
  • Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all